“Where there is an epidemic, there will be a need for testing.” Now the spread of a new round of mutant viruses has tightened the epidemic prevention and control work at home and abroad. With the affirmation of antigen rapid test products and the advocacy of home self-test in many countries and regions, the international market for antigen rapid test products is still in short supply.
Beijing Jinwofu Bioengineering Technology Co., Ltd was established in 2006. It is a comprehensive medical device high-tech enterprise integrating product research and development, production, sales and service. There are two production and office premises with a total area of approximately 5,400 sq. ft. Among them, a new cleanroom meeting the requirements of GMP specifications was built in 2022, with an area of nearly 750 sq. ft. It met the production needs of Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test Kit and other products.
Our company focuses on both domestic and global markets. We have obtained more than 100 CE record certificates covering respiratory system testing products, digestive system testing products, eugenics series testing products, venereal disease series testing products, infectious disease series testing products, etc. We have become a world-renowned supplier of in vitro diagnostic reagents with high quality.
Our company has formed a series of colloidal gold method, color latex method rapid immunodiagnostic reagents and immunofluorescence quantitative POCT products with independent intellectual property rights, and has more than 20 medical device registration certificates in gynecology, pediatrics, gastroenterology and respiratory departments, including 20 third-class medical device registration certificates. It has become the domestic manufacturer that has obtained the most third-class medical device registration certificates and a relatively complete range in the field of gynecology.
Jinwofu is also actively exploring overseas market, its products have been sold in many countries and regions and has obtained good feedback from users. Please check the following multi-country access list and look forward to cooperating with you!
Post time: Mar-01-2023